id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-D-0147-0039,FDA,FDA-2011-D-0147,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2021-12-30T05:00:00Z,2021,12,2021-12-30T05:00:00Z,,2021-12-30T14:30:37Z,2021-28362,0,0,0900006484f005d2
FDA-2011-D-0147-0038,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approvals",Notice,Information Collection Request (ICR),2019-11-07T05:00:00Z,2019,11,2019-11-07T05:00:00Z,,2019-11-07T15:02:40Z,2019-24263,0,0,09000064841282e3
FDA-2011-D-0147-0037,FDA,FDA-2011-D-0147,Guidance for Industry and FDA Staff:  Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products,Other,Guidance,2019-06-05T04:00:00Z,2019,6,2019-06-05T04:00:00Z,,2024-11-12T23:02:14Z,,1,0,0900006483cec52f
FDA-2011-D-0147-0036,FDA,FDA-2011-D-0147,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry and Food and Drug Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products,Notice,30 Day Proposed Information Collection,2019-06-05T04:00:00Z,2019,6,2019-06-05T04:00:00Z,2019-07-06T03:59:59Z,2019-06-05T13:05:11Z,2019-11657,0,0,0900006483cebdee
FDA-2011-D-0147-0028,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Guidance for Industry and Food and Drug
Administration Staff; Section 905(j) Reports: Demonstrating Substantial
Equivalence for Tobacco Products",Notice,60 Day Proposed Information Collection,2018-09-06T04:00:00Z,2018,9,2018-09-06T04:00:00Z,2018-11-06T04:59:59Z,2018-11-07T02:10:50Z,2018-19353,0,0,09000064836af568
FDA-2011-D-0147-0025,FDA,FDA-2011-D-0147,"Guidance for Industry; Demonstrating the Substantial Equivalence of a
New Tobacco Product: Responses to Frequently Asked Questions (Edition 3)",Other,Guidance,2016-12-14T05:00:00Z,2016,12,2016-12-14T05:00:00Z,,2024-11-07T23:50:17Z,,1,0,0900006482406b59
FDA-2011-D-0147-0024,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Announcement of Office of
Management and Budget Approval; Guidance for Industry and Food and
Drug Administration Staff; Section 905(j) Reports: Demonstrating
Substantial Equivalence for Tobacco Products and Demonstrating the
Substantial Equivalence of a New Tobacco Product: Responses to
Frequently Asked Questions",Notice,Notice of Approval,2016-02-29T05:00:00Z,2016,2,2016-02-29T05:00:00Z,,2016-03-02T17:05:45Z,2016-04222,0,0,0900006481e8f4c8
FDA-2011-D-0147-0023,FDA,FDA-2011-D-0147,Guidance for Industry Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions (Edition 2),Other,Guidance,2015-09-08T04:00:00Z,2015,9,2015-09-08T04:00:00Z,,2024-11-11T21:10:29Z,,1,0,0900006481c5df94
FDA-2011-D-0147-0022,FDA,FDA-2011-D-0147,"Demonstrating the Substantial Equivalence of a New Tobacco
Product: Responses to Frequently Asked Questions; Second Edition;
Guidance for Industry; Availability",Notice,Notice of Availability,2015-09-08T04:00:00Z,2015,9,2015-09-08T04:00:00Z,,2015-09-08T13:38:38Z,2015-22494,0,0,0900006481c5dd92
FDA-2011-D-0147-0019,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Submission for Office of
Management and Budget Review; Comment Request; Guidance for
Industry and Food and Drug Administration Staff; Section 905(j)
Reports: Demonstrating Substantial Equivalence for Tobacco Products and Demonstrating the Substantial Equivalence of a New Tobacco
Product: Responses to Frequently Asked Questions",Notice,30 Day Proposed Information Collection,2015-07-13T04:00:00Z,2015,7,2015-07-13T04:00:00Z,2015-08-13T03:59:59Z,2015-07-13T13:51:03Z,2015-16952,0,0,0900006481b7d8b5
FDA-2011-D-0147-0018,FDA,FDA-2011-D-0147,Guidance for Industry Demonstrating the Substantial Equivalence of a New Tobacco Product-Responses to Frequently Asked Questions 5 2015,Other,Guidance,2015-06-01T04:00:00Z,2015,6,2015-06-01T04:00:00Z,,2015-07-01T14:31:00Z,,0,0,0900006481b134cd
FDA-2011-D-0147-0008,FDA,FDA-2011-D-0147,"Agency Information Collection Activities; Proposed Collection;
Comment Request; Guidance for Industry and Food and Drug
Administration Staff; Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products and Demonstrating the Substantial Equivalence of a New Tobacco Product: Responses to Frequently Asked Questions",Notice,60 Day Proposed Information Collection,2015-03-05T05:00:00Z,2015,3,2015-03-05T05:00:00Z,2015-05-05T03:59:59Z,2024-06-20T23:28:28Z,2015-05024,0,0,0900006481a2e27c
FDA-2011-D-0147-0009,FDA,FDA-2011-D-0147,"Demonstrating the Substantial Equivalence of a New Tobacco
Product: Responses to Frequently Asked Questions; Guidance for
Industry; Availability",Notice,Notice of Availability,2015-03-05T05:00:00Z,2015,3,2015-03-05T05:00:00Z,,2016-03-02T16:50:33Z,2015-05023,0,0,0900006481a2dc3f
FDA-2011-D-0147-0010,FDA,FDA-2011-D-0147,"Demonstrating the Substantial Equivalence of a New Tobacco
Product: Responses to Frequently Asked Questions; Guidance for
Industry Availability",Other,Guidance,2015-03-05T05:00:00Z,2015,3,2015-03-05T05:00:00Z,,2024-11-07T23:18:27Z,,1,0,0900006481a2e31a
FDA-2011-D-0147-0002,FDA,FDA-2011-D-0147,Draft Guidance for Staff Demonstrating Substantial Equivalence of New Tobacco Product; Responses to Frequently Asked Questions,Other,Guidance,2011-09-09T04:00:00Z,2011,9,2011-09-09T04:00:00Z,2011-11-09T04:59:59Z,2015-07-01T14:29:54Z,,0,0,0900006480f146e5
FDA-2011-D-0147-0001,FDA,FDA-2011-D-0147,Draft Guidance for Staff; Availability: Demonstrating Substantial Equivalence of New Tobacco Product; Responses to Frequently Asked Questions,Notice,Notice of Availability,2011-09-09T04:00:00Z,2011,9,2011-09-09T04:00:00Z,2011-11-09T04:59:59Z,2016-03-02T16:51:14Z,2011-23100,0,0,0900006480f14df8